Induction ChemotherapyAntineoplastic Combined Chemotherapy ProtocolsAntibodies, Monoclonal, HumanizedCisplatinCombined Modality TherapyRemission InductionChemotherapy, AdjuvantAntineoplastic AgentsTreatment OutcomeDisease-Free SurvivalHead and Neck NeoplasmsAntibodies, MonoclonalCarcinoma, Squamous CellSurvival AnalysisNeoadjuvant TherapyFluorouracilSurvival RateNeoplasm StagingCyclophosphamideEtoposideLung NeoplasmsCarboplatinCytarabineTaxoidsDoxorubicinLeukemia, Myeloid, AcutePaclitaxelDrug Administration ScheduleDaunorubicinReceptor, Epidermal Growth FactorPrognosisOrganoplatinum CompoundsColorectal NeoplasmsCamptothecinCarcinoma, Non-Small-Cell LungChemoradiotherapyIfosfamideRadiotherapy, AdjuvantDeoxycytidineVincristineEnzyme InductionNeoplasm Recurrence, LocalDrug Resistance, NeoplasmHypopharyngeal NeoplasmsNeoplasm MetastasisPrecursor Cell Lymphoblastic Leukemia-LymphomaVinblastineRadiotherapyKaplan-Meier EstimateMethotrexateIdarubicinLaryngectomyRadiotherapy Dosageras ProteinsSalvage TherapyBleomycinLeucovorinLeukemia, MyeloidBreast NeoplasmsTransplantation, AutologousFollow-Up StudiesTime FactorsNasopharyngeal NeoplasmsNeutropeniaAdenocarcinomaDose-Response Relationship, DrugLaryngeal NeoplasmsProspective StudiesMelphalanCell Line, TumorGranulocyte Colony-Stimulating FactorAntimetabolites, AntineoplasticTesticular NeoplasmsAsparaginaseDose FractionationExanthemaMucositisOrgan Sparing TreatmentsOropharyngeal NeoplasmsMitoxantroneClinical Trials as TopicLevoleucovorinVindesineCranial IrradiationHematopoietic Stem Cell TransplantationAcneiform EruptionsGlossectomyRadiotherapy, High-EnergyDisease ProgressionConsolidation ChemotherapyFeasibility StudiesTumor Markers, BiologicalThiotepaInfusions, IntravenousMesnaNeoplasms, Germ Cell and EmbryonalAnthracyclinesNeoplasmsNeoplasm, ResidualAcute Disease